From researchers to executives, people in the biotechnology industry are always thinking about raising more capital to help fund the endless research and development needed to make technological breakthroughs.
But the sector may have to pay more attention on marketing and branding if it wants to stand out from competitors in the global arena, the head of the semi-official Industrial Technology Research Institute (ITRI) said yesterday at a marketing forum in Taipei.
"Anything that remains local will lose the potential for development," ITRI president Johnsee Lee (李鍾熙) said. "But marketing and networking with international alliances will strengthen our biotech industry."
The forum on marketing for Asian life-science companies was held by BiotechEast Co (東方生技), a Taipei-based public relations and marketing consultancy specializing in the biotech industry.
The firm also signed an agreement with Frost & Sullivan yesterday, making it the sole agent in this country for the New York-based, high-tech market consultancy.
"Taiwan must improve its collaborative efforts with the global life-science community through increased attention to marketing, promotion and networking abroad," BiotechEast president David Silver said.
Marketing and branding is critical to the nation's biotech industry, given the keen competition from regional rivals such as South Korea and Singapore, he said.
Silver said South Korea emphasized its international presence by setting up research units in other countries including the UK, China and Israel in recent years. It also established "Korea BioValley" last year in San Diego, California, the hub of biotechnology, he said.
Singapore places a strong emphasis on overseas promotions, keeps a high profile in international media such as CNN and seeks out international companies for foreign talent, such as ES Cell International, an Australian company that recruited Alan Colman, who became famous for cloning the sheep "Dolly" in 1997.
Taiwan's biotech industry, however, doesn't have enough information available for the international community for those seeking collaboration or investment, said Chen Chei-hsiang (陳啟祥), director of the Biotechnology & Pharmaceutical Industries Program Office (BPIPO) under the Ministry of Economic Affairs.
"We are considering helping the industry promote itself to the world to enhance global visibility," Chen said.
In 2002, the government announced it would promote the biotech industry for the next 10 years, making it one of the key sectors in the "2 Trillion, Twin Star" investment plan. Annual revenues in the industry rose 13 percent to NT$125.6 billion last year from NT$110.9 billion in 2002, according to figures provided by BPIPO.
The government plans to pour NT$150 billion into the sector by 2006, hoping to boost annual revenue to NT$250 billion by 2006.
"The Taiwanese biotech industry has great advantages in terms of government support, strong technological background and robust financial environment to acquire capital," said Aditya Sapru, Frost & Sullivan's director of biotech life science practice in the Asia-Pacific region.
Intel Corp chief executive officer Lip-Bu Tan (陳立武) is expected to meet with Taiwanese suppliers next month in conjunction with the opening of the Computex Taipei trade show, supply chain sources said on Monday. The visit, the first for Tan to Taiwan since assuming his new post last month, would be aimed at enhancing Intel’s ties with suppliers in Taiwan as he attempts to help turn around the struggling US chipmaker, the sources said. Tan is to hold a banquet to celebrate Intel’s 40-year presence in Taiwan before Computex opens on May 20 and invite dozens of Taiwanese suppliers to exchange views
Application-specific integrated circuit designer Faraday Technology Corp (智原) yesterday said that although revenue this quarter would decline 30 percent from last quarter, it retained its full-year forecast of revenue growth of 100 percent. The company attributed the quarterly drop to a slowdown in customers’ production of chips using Faraday’s advanced packaging technology. The company is still confident about its revenue growth this year, given its strong “design-win” — or the projects it won to help customers design their chips, Faraday president Steve Wang (王國雍) told an online earnings conference. “The design-win this year is better than we expected. We believe we will win
Chizuko Kimura has become the first female sushi chef in the world to win a Michelin star, fulfilling a promise she made to her dying husband to continue his legacy. The 54-year-old Japanese chef regained the Michelin star her late husband, Shunei Kimura, won three years ago for their Sushi Shunei restaurant in Paris. For Shunei Kimura, the star was a dream come true. However, the joy was short-lived. He died from cancer just three months later in June 2022. He was 65. The following year, the restaurant in the heart of Montmartre lost its star rating. Chizuko Kimura insisted that the new star is still down
While China’s leaders use their economic and political might to fight US President Donald Trump’s trade war “to the end,” its army of social media soldiers are embarking on a more humorous campaign online. Trump’s tariff blitz has seen Washington and Beijing impose eye-watering duties on imports from the other, fanning a standoff between the economic superpowers that has sparked global recession fears and sent markets into a tailspin. Trump says his policy is a response to years of being “ripped off” by other countries and aims to bring manufacturing to the US, forcing companies to employ US workers. However, China’s online warriors
RSS